Ultra Violette Brings FDA-Approved BEMT Sunscreen to the US Market

According to HBW Insight, Australian suncare brand Ultra Violette has launched its Unblock Screen SPF 50 Breakout-Friendly in the United States — the first sunscreen commercialized in the US market built around bemotrizinol (BEMT), a broad-spectrum organic UV filter newly approved by the FDA. The formula targets oily, acne-prone, and reactive skin, a demographic that mainstream chemical sunscreen development has historically underserved.

What BEMT changes for acne-prone skin

Bemotrizinol is a broad-spectrum organic filter that absorbs across both UVA and UVB wavelengths in a single molecule. Before FDA clearance, BEMT had been available in Australian, European, and Asian sunscreen markets for years. Its US debut through an Australian independent brand — rather than a legacy American manufacturer — is the structural shift worth noting.

For oily and acne-prone users, the practical relevance lies in the filter's oil-soluble character and its capacity to deliver broad-spectrum coverage without the high solvent concentrations that destabilize many chemical sunscreen vehicles.

The formula breakdown

The Unblock Screen combines BEMT with three secondary actives: zinc oxide, Bix'Activ, and Pentavitin.

Zinc oxide functions as a secondary mineral filter, closing spectral gaps that organic filters can leave. Bix'Activ is positioned as an oil-regulating active, included to address excess sebum output in breakout-prone users. Pentavitin is a saccharide-based humectant complex included for lightweight hydration without heavy occlusive agents.

The structural combination — organic and mineral filters paired with sebum control and non-occlusive hydration — is designed to avoid the trade-offs that typically force acne-prone consumers to choose between adequate UV protection and a tolerable vehicle.

What to verify before purchase

For US consumers, confirm BEMT appears on the ingredient label under its INCI designation. The product should carry an FDA broad-spectrum claim, which certifies the formula meets the UVA protection threshold required under US regulation.

For acne-prone users specifically, the inclusion of an oil-regulating active does not eliminate comedogenicity risk. Comedogenicity is determined primarily by the vehicle — the emulsifiers, esters, and fatty alcohols that hold the formula together — rather than by the named actives. A 48-hour patch test on the jawline or behind the ear remains the standard screening step before full facial application.

The verdict

This launch moves an established broad-spectrum filter from regulatory backlog to US retail. Whether Ultra Violette's specific formulation delivers on the breakout-friendly positioning depends on the full ingredient deck, which was not included in the available reporting. The filter technology is sound; the vehicle is what determines whether the product performs as claimed on oily and acne-prone skin.